TY - JOUR
T1 - Haploinsufficiency of RREB1 causes a Noonan-like RASopathy via epigenetic reprogramming of RAS-MAPK pathway genes
AU - Kent, Oliver A.
AU - Saha, Manipa
AU - Coyaud, Etienne
AU - Burston, Helen E.
AU - Law, Napoleon
AU - Dadson, Keith
AU - Chen, Sujun
AU - Laurent, Estelle M.
AU - St-Germain, Jonathan
AU - Sun, Ren X.
AU - Matsumoto, Yoshinori
AU - Cowen, Justin
AU - Montgomery-Song, Aaryn
AU - Brown, Kevin R.
AU - Ishak, Charles
AU - Rose, Jose La
AU - De Carvalho, Daniel D.
AU - He, Housheng Hansen
AU - Raught, Brian
AU - Billia, Filio
AU - Kannu, Peter
AU - Rottapel, Robert
N1 - Funding Information:
The authors thank the patient’s family for their participation and feedback. We thank the many colleagues who offered helpful comments and discussion. The work was supported by a CIHR foundation scheme Grant No. 410005207.
Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12/1
Y1 - 2020/12/1
N2 - RAS-MAPK signaling mediates processes critical to normal development including cell proliferation, survival, and differentiation. Germline mutation of RAS-MAPK genes lead to the Noonan-spectrum of syndromes. Here, we present a patient affected by a 6p-interstitial microdeletion with unknown underlying molecular etiology. Examination of 6p-interstitial microdeletion cases reveals shared clinical features consistent with Noonan-spectrum disorders including short stature, facial dysmorphia and cardiovascular abnormalities. We find the RAS-responsive element binding protein-1 (RREB1) is the common deleted gene in multiple 6p-interstitial microdeletion cases. Rreb1 hemizygous mice display orbital hypertelorism and cardiac hypertrophy phenocopying the human syndrome. Rreb1 haploinsufficiency leads to sensitization of MAPK signaling. Rreb1 recruits Sin3a and Kdm1a to control H3K4 methylation at MAPK pathway gene promoters. Haploinsufficiency of SIN3A and mutations in KDM1A cause syndromes similar to RREB1 haploinsufficiency suggesting genetic perturbation of the RREB1-SIN3A-KDM1A complex represents a new category of RASopathy-like syndromes arising through epigenetic reprogramming of MAPK pathway genes.
AB - RAS-MAPK signaling mediates processes critical to normal development including cell proliferation, survival, and differentiation. Germline mutation of RAS-MAPK genes lead to the Noonan-spectrum of syndromes. Here, we present a patient affected by a 6p-interstitial microdeletion with unknown underlying molecular etiology. Examination of 6p-interstitial microdeletion cases reveals shared clinical features consistent with Noonan-spectrum disorders including short stature, facial dysmorphia and cardiovascular abnormalities. We find the RAS-responsive element binding protein-1 (RREB1) is the common deleted gene in multiple 6p-interstitial microdeletion cases. Rreb1 hemizygous mice display orbital hypertelorism and cardiac hypertrophy phenocopying the human syndrome. Rreb1 haploinsufficiency leads to sensitization of MAPK signaling. Rreb1 recruits Sin3a and Kdm1a to control H3K4 methylation at MAPK pathway gene promoters. Haploinsufficiency of SIN3A and mutations in KDM1A cause syndromes similar to RREB1 haploinsufficiency suggesting genetic perturbation of the RREB1-SIN3A-KDM1A complex represents a new category of RASopathy-like syndromes arising through epigenetic reprogramming of MAPK pathway genes.
UR - http://www.scopus.com/inward/record.url?scp=85090995954&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090995954&partnerID=8YFLogxK
U2 - 10.1038/s41467-020-18483-9
DO - 10.1038/s41467-020-18483-9
M3 - Article
C2 - 32938917
AN - SCOPUS:85090995954
SN - 2041-1723
VL - 11
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 4673
ER -